HUP0102321A3 - Acylbenzoxazines for enhancing synaptic response(s) and their use - Google Patents

Acylbenzoxazines for enhancing synaptic response(s) and their use

Info

Publication number
HUP0102321A3
HUP0102321A3 HU0102321A HUP0102321A HUP0102321A3 HU P0102321 A3 HUP0102321 A3 HU P0102321A3 HU 0102321 A HU0102321 A HU 0102321A HU P0102321 A HUP0102321 A HU P0102321A HU P0102321 A3 HUP0102321 A3 HU P0102321A3
Authority
HU
Hungary
Prior art keywords
acylbenzoxazines
synaptic response
enhancing synaptic
enhancing
response
Prior art date
Application number
HU0102321A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of HUP0102321A2 publication Critical patent/HUP0102321A2/hu
Publication of HUP0102321A3 publication Critical patent/HUP0102321A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HU0102321A 1998-04-03 1999-04-02 Acylbenzoxazines for enhancing synaptic response(s) and their use HUP0102321A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/054,916 US6124278A (en) 1998-04-03 1998-04-03 Acylbenzoxazines for enhancing synaptic response
PCT/US1999/007325 WO1999051240A1 (en) 1998-04-03 1999-04-02 Acylbenzoxazines for enhancing synaptic response(s)

Publications (2)

Publication Number Publication Date
HUP0102321A2 HUP0102321A2 (hu) 2001-11-28
HUP0102321A3 true HUP0102321A3 (en) 2002-01-28

Family

ID=21994357

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102321A HUP0102321A3 (en) 1998-04-03 1999-04-02 Acylbenzoxazines for enhancing synaptic response(s) and their use

Country Status (22)

Country Link
US (1) US6124278A (xx)
EP (1) EP1067935B1 (xx)
JP (1) JP4574846B2 (xx)
KR (1) KR100646753B1 (xx)
CN (1) CN1186020C (xx)
AT (1) ATE247472T1 (xx)
BR (1) BR9909378A (xx)
CA (1) CA2326764C (xx)
CZ (1) CZ292931B6 (xx)
DE (1) DE69910552T2 (xx)
DK (1) DK1067935T3 (xx)
ES (1) ES2207194T3 (xx)
HK (1) HK1039060B (xx)
HU (1) HUP0102321A3 (xx)
IL (1) IL138284A0 (xx)
NO (1) NO20004383L (xx)
NZ (1) NZ506712A (xx)
PL (1) PL195394B1 (xx)
PT (1) PT1067935E (xx)
RU (1) RU2246498C2 (xx)
TR (1) TR200002849T2 (xx)
WO (1) WO1999051240A1 (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI232863B (en) 2001-06-11 2005-05-21 Akzo Nobel Nv Benzoxazepine derivatives
CN1255413C (zh) 2001-06-14 2006-05-10 阿克佐诺贝尔公司 作为ampa受体正性调节剂的(吡啶并/噻吩并)－[f]－氧杂吖庚因－5－酮衍生物
US7799913B2 (en) * 2001-11-26 2010-09-21 Cortex Pharmaceuticals, Inc. Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses
WO2009019032A2 (en) * 2003-08-08 2009-02-12 Dsm Ip Assets B.V. Novel method for screening brain-active compounds
TW200800959A (en) 2005-06-10 2008-01-01 Wyeth Corp Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
TW200901974A (en) 2007-01-16 2009-01-16 Wyeth Corp Compounds, compositions, and methods of making and using them
NZ589671A (en) * 2008-06-06 2012-03-30 Sanofi Aventis Macrocyclic urea and sulfamide derivatives as inhibitors of tafia
WO2010054336A2 (en) * 2008-11-10 2010-05-14 The Regents Of The University Of California Therapeutic uses of ampa receptor modulators for treatment of motor dysfunction
AU2014277952A1 (en) 2013-06-13 2016-01-28 Veroscience Llc Compositions and methods for treating metabolic disorders
CN108689876B (zh) * 2018-06-28 2020-11-27 苏州东南药业股份有限公司 一种8-(2-羟基苯甲酰胺基)辛酸钠的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0475908A1 (de) * 1990-09-14 1992-03-18 Ciba-Geigy Ag Chromogene Lactamverbindungen und ihre Herstellung und Verwendung
EP1156043B1 (en) * 1992-07-24 2003-11-12 The Regents Of The University Of California Drugs that enhance synaptic responses mediated by ampa receptors
US5650409A (en) * 1995-06-02 1997-07-22 Cortex Pharmaceuticals, Inc. Benzoyl piperidines/pyrrolidines for enhancing synaptic response
US5736543A (en) * 1996-04-03 1998-04-07 The Regents Of The University Of California Benzoxazines for enhancing synaptic response
US5985871A (en) * 1997-12-24 1999-11-16 Cortex Pharmaceuticals, Inc. Benzoxazine compounds for enhancing synaptic response

Also Published As

Publication number Publication date
DE69910552T2 (de) 2004-06-17
KR100646753B1 (ko) 2006-11-17
CN1306427A (zh) 2001-08-01
WO1999051240A1 (en) 1999-10-14
NO20004383D0 (no) 2000-09-04
NO20004383L (no) 2000-10-09
CZ292931B6 (cs) 2004-01-14
EP1067935B1 (en) 2003-08-20
KR20010042192A (ko) 2001-05-25
HK1039060A1 (en) 2002-04-12
JP4574846B2 (ja) 2010-11-04
ES2207194T3 (es) 2004-05-16
CN1186020C (zh) 2005-01-26
CZ20003614A3 (cs) 2001-01-17
PL195394B1 (pl) 2007-09-28
ATE247472T1 (de) 2003-09-15
CA2326764C (en) 2010-12-14
TR200002849T2 (tr) 2001-06-21
CA2326764A1 (en) 1999-10-14
IL138284A0 (en) 2001-10-31
EP1067935A4 (en) 2001-10-04
WO1999051240A8 (en) 2001-03-22
US6124278A (en) 2000-09-26
BR9909378A (pt) 2000-12-05
PL345687A1 (en) 2002-01-02
DK1067935T3 (da) 2003-11-24
PT1067935E (pt) 2004-01-30
HK1039060B (zh) 2005-05-13
NZ506712A (en) 2002-11-26
AU3379899A (en) 1999-10-25
EP1067935A1 (en) 2001-01-17
RU2246498C2 (ru) 2005-02-20
AU736376B2 (en) 2001-07-26
JP2002510635A (ja) 2002-04-09
HUP0102321A2 (hu) 2001-11-28
DE69910552D1 (de) 2003-09-25

Similar Documents

Publication Publication Date Title
EP1032377A4 (en) SUBSTITUTED 2-AMINOACETAMIDES AND APPLICATION THEREOF
GB9717906D0 (en) Sensor Devices And Analytical Methods
EP1037635A4 (en) CONNECTIONS AROUND METHODS
GB9722032D0 (en) Identifying substances
HUP9801511A3 (en) Human semaphorin-l (h-sema-l) and corresponding semaphorine in other species
GB9702354D0 (en) Compounds and their use
HUP0103473A3 (en) Phosphoglycolipid and methods for its use
HUP0102321A3 (en) Acylbenzoxazines for enhancing synaptic response(s) and their use
GB9716749D0 (en) Sensor devices and analytical methods using them
GB0002566D0 (en) Sensor devices and analytical methods using them
GB9727518D0 (en) Use
GB9707743D0 (en) Analysis
HUP0104723A3 (en) New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use
IL131247A0 (en) Cash protein its preparation and use
IL123535A0 (en) Benzoxazindione derivatives and their use
EP0744125A3 (en) Iodine complex and its application
IL145711A0 (en) Thrombospondin-2 and uses thereof
GB9719315D0 (en) Improvements in pesticides
EP0998578A4 (en) SEL-10 AND USES OF SEL-10
GB9704162D0 (en) Assay methods and means
GB9710623D0 (en) Carrying device
GB9713921D0 (en) Biological data
GB9813778D0 (en) Assay methods and means
PL341293A1 (en) Beta-lypothropin and application thereof
PL338379A1 (en) Novel photoinitiators and their application

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees